Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 2.871
Filter
1.
Invest Ophthalmol Vis Sci ; 65(10): 18, 2024 Aug 01.
Article in English | MEDLINE | ID: mdl-39120913

ABSTRACT

Purpose: A micrometer scale hyporeflective band within the retinal pigment epithelium basal lamina - Bruch's membrane complex (RPE-BL-BrM) was topographically measured in aging and age-related macular degeneration (AMD). Methods: In a prospective cross-sectional study, 90 normal eyes from 76 subjects (range = 23-90 years) and 53 dry AMD eyes from 47 subjects (range = 62-91 years) were enrolled. Isotropic volume raster scans over 6 mm × 6 mm (500 × 500 A-scans) were acquired using a high-resolution (2.7 µm axial resolution) spectral-domain optical coherence tomography (SD-OCT) prototype instrument. Six consecutive optical coherence tomography (OCT) volumes were computationally motion-corrected and fused to improve feature visibility. A boundary regression neural network was developed to measure hyporeflective band thickness. Topographic dependence was evaluated over a 6-mm-diameter Early Treatment Diabetic Retinopathy Study (ETDRS) grid. Results: The hyporeflective band thickness map (median of 4.3 µm and 7.8 µm in normal and AMD eyes, respectively) is thicker below and radially symmetric around the fovea. In normal eyes, age-associated differences occur within 0.7 to 2.3 mm from the foveal center (P < 0.05). In AMD eyes, the hyporeflective band is hypothesized to be basal laminar deposits (BLamDs) and is thicker within the 3-mm ETDRS circle (P < 0.0002) compared with normal eyes. The inner ring is the most sensitive location to detect age versus AMD-associated changes within the RPE-BL-BrM. AMD eyes with subretinal drusenoid deposits (SDDs) have a significantly thicker hyporeflective band (P < 0.001) than those without SDDs. Conclusions: The hyporeflective band is a quantifiable biomarker which differentiates AMD from aging. Longitudinal studies are warranted. The hyporeflective band may be a useful biomarker for risk stratification and disease progression.


Subject(s)
Aging , Retinal Pigment Epithelium , Tomography, Optical Coherence , Humans , Tomography, Optical Coherence/methods , Retinal Pigment Epithelium/pathology , Retinal Pigment Epithelium/diagnostic imaging , Aged , Middle Aged , Prospective Studies , Cross-Sectional Studies , Female , Male , Aged, 80 and over , Aging/physiology , Adult , Young Adult , Bruch Membrane/pathology , Bruch Membrane/diagnostic imaging , Macular Degeneration/diagnosis , Macular Degeneration/physiopathology
2.
BMC Ophthalmol ; 24(1): 327, 2024 Aug 06.
Article in English | MEDLINE | ID: mdl-39107704

ABSTRACT

BACKGROUND: Occult Macular Dystrophy (OMD), primarily caused by retinitis pigmentosa 1-like 1 (RP1L1) variants, is a complex retinal disease characterised by progressive vision loss and a normal fundus appearance. This study aims to investigate the diverse phenotypic expressions and genotypic correlations of OMD in Chinese patients, including a rare case of Vitelliform Macular Dystrophy (VMD) associated with RP1L1. METHODS: We analysed seven OMD patients and one VMD patient, all with heterozygous pathogenic RP1L1 variants. Clinical assessments included Best Corrected Visual Acuity (BCVA), visual field testing, Spectral Domain Optical Coherence Tomography (SD-OCT), multifocal Electroretinograms (mfERGs), and microperimetry. Next-generation sequencing was utilised for genetic analysis. RESULTS: The OMD patients displayed a range of phenotypic variability. Most (5 out of 7) had the RP1L1 variant c.133 C > T; p.R45W, associated with central vision loss and specific patterns in SD-OCT and mfERG. Two patients exhibited different RP1L1 variants (c.3599G > T; p.G1200V and c.2880G > C; p.W960C), presenting milder phenotypes. SD-OCT revealed photoreceptor layer changes, with most patients showing decreased mfERG responses in the central rings. Interestingly, a unique case of VMD linked to the RP1L1 variant was observed, distinct from traditional OMD presentations. CONCLUSIONS: This study highlights the phenotypic diversity within OMD and the broader spectrum of RP1L1-associated macular dystrophies, including a novel association with VMD. The findings emphasise the complexity of RP1L1 variants in determining clinical manifestations, underscoring the need for comprehensive genetic and clinical evaluations in macular dystrophies.


Subject(s)
Electroretinography , Eye Proteins , Microtubule-Associated Proteins , Tomography, Optical Coherence , Visual Acuity , Vitelliform Macular Dystrophy , Humans , Male , Female , Tomography, Optical Coherence/methods , Adult , Middle Aged , Eye Proteins/genetics , Visual Acuity/physiology , Vitelliform Macular Dystrophy/genetics , Vitelliform Macular Dystrophy/physiopathology , Vitelliform Macular Dystrophy/diagnosis , Microtubule-Associated Proteins/genetics , Visual Fields/physiology , China/epidemiology , Young Adult , Visual Field Tests , Pedigree , Adolescent , Phenotype , Mutation , Macular Degeneration/genetics , Macular Degeneration/diagnosis , Macular Degeneration/physiopathology , Asian People/genetics , Aged , East Asian People
3.
J Patient Rep Outcomes ; 8(1): 89, 2024 Aug 12.
Article in English | MEDLINE | ID: mdl-39133415

ABSTRACT

BACKGROUND: Neovascular age-related macular degeneration (nAMD) is a common cause of visual impairment and blindness in the elderly with globally increasing prevalence. Vascular endothelial growth factor inhibitor (anti-VEGF) treatment has improved visual prognosis of nAMD, but continuous treatment may cause anxiety and stress, although increase in visual acuity (VA) may also have positive effects on patients' quality of life. The health care burden due to frequent treatment and monitoring is apparent, but the effect of anti-VEGF treatment on patients' quality of life is not fully understood. We evaluated the overall impact of nAMD and its treatment on newly diagnosed patients' health-related quality of life (HRQoL) in real-world setting. METHODS: The present prospective cohort study included newly diagnosed nAMD patients treated with anti-VEGF injections at Oulu University Hospital during 2019-2020. Data included parameters from comprehensive ophthalmic examination and fundus imaging, age at diagnosis, sex, comorbidities, visual acuity, and frequency of anti-VEGF injections. HRQoL was assessed by 15D questionnaire at diagnosis, 6 months, and 12 months. RESULTS: 95 nAMD patients were included. They were 78 ± 8 years old, 56 (59%) were female, and 74 (78%) had more than one comorbidity. The patients received 8 ± 3 anti-VEGF-injections. Visual acuity (VA) improved from 56 ± 18 to 61 ± 24 Early treatment diabetic retinopathy study (ETDRS) letters in 12 months. VA improved > 5 ETDRS letters in 45 (47%), remained stable in 30 (32%) and decreased > 5 letters in 17 (18%) eyes. The mean total 15D score reflecting overall HRQoL decreased from 0.850 ± 0.104 to 0.834 ± 0.103 in 12 months. Decreased HRQoL was associated with baseline best-corrected VA (BCVA) ≥ 70 ETDRS letters (p = 0.023) and more than one comorbidity (p = 0.034). HRQoL regarding visual function increased from 0.765 ± 0.194 to 0.789 ± 0.184 during the 12-month follow-up. CONCLUSIONS: In real world setting, HRQoL regarding visual function improved in anti-VEGF-treated nAMD patients during the first 12 months after the diagnosis and treatment initiation. Good baseline VA or several comorbidities were associated with decreased overall HRQoL during the follow-up. Despite the effectiveness of anti-VEGF treatment on visual function, several other aspects affecting elderly patients' everyday life should be considered when nAMD treatment is implemented.


Subject(s)
Angiogenesis Inhibitors , Quality of Life , Visual Acuity , Humans , Male , Female , Aged , Prospective Studies , Visual Acuity/drug effects , Angiogenesis Inhibitors/therapeutic use , Angiogenesis Inhibitors/adverse effects , Aged, 80 and over , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Macular Degeneration/drug therapy , Macular Degeneration/physiopathology , Surveys and Questionnaires , Wet Macular Degeneration/drug therapy , Wet Macular Degeneration/physiopathology , Wet Macular Degeneration/psychology , Cohort Studies
4.
Invest Ophthalmol Vis Sci ; 65(8): 13, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38975944

ABSTRACT

Purpose: This study aims at linking subtle changes of fixational eye movements (FEM) in controls and in patients with foveal drusen using adaptive optics retinal imaging in order to find anatomo-functional markers for pre-symptomatic age-related macular degeneration (AMD). Methods: We recruited 7 young controls, 4 older controls, and 16 patients with presymptomatic AMD with foveal drusen from the Silversight Cohort. A high-speed research-grade adaptive optics flood illumination ophthalmoscope (AO-FIO) was used for monocular retinal tracking of fixational eye movements. The system allows for sub-arcminute resolution, and high-speed and distortion-free imaging of the foveal area. Foveal drusen position and size were documented using gaze-dependent imaging on a clinical-grade AO-FIO. Results: FEM were measured with high precision (RMS-S2S = 0.0015 degrees on human eyes) and small foveal drusen (median diameter = 60 µm) were detected with high contrast imaging. Microsaccade amplitude, drift diffusion coefficient, and ISOline area (ISOA) were significantly larger for patients with foveal drusen compared with controls. Among the drusen participants, microsaccade amplitude was correlated to drusen eccentricity from the center of the fovea. Conclusions: A novel high-speed high-precision retinal tracking technique allowed for the characterization of FEM at the microscopic level. Foveal drusen altered fixation stability, resulting in compensatory FEM changes. Particularly, drusen at the foveolar level seemed to have a stronger impact on microsaccade amplitudes and ISOA. The unexpected anatomo-functional link between small foveal drusen and fixation stability opens up a new perspective of detecting oculomotor signatures of eye diseases at the presymptomatic stage.


Subject(s)
Fixation, Ocular , Fovea Centralis , Macular Degeneration , Retinal Drusen , Humans , Female , Retinal Drusen/physiopathology , Retinal Drusen/diagnosis , Male , Fixation, Ocular/physiology , Fovea Centralis/diagnostic imaging , Fovea Centralis/physiopathology , Fovea Centralis/pathology , Aged , Middle Aged , Macular Degeneration/physiopathology , Macular Degeneration/diagnosis , Adult , Tomography, Optical Coherence/methods , Ophthalmoscopy/methods , Visual Acuity/physiology , Saccades/physiology , Prodromal Symptoms
5.
Invest Ophthalmol Vis Sci ; 65(8): 36, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-39028975

ABSTRACT

Purpose: The purpose of this study was to assess the choroidal thickness and the Bruch's membrane opening size and their relationship to visual acuity in eyes with myopic macular degeneration (MMD). Methods: This was a population-based, cross-sectional study. Patients over the age of 30 years with high myopia (spherical equivalent ≤-5 diopters [D]) were recruited. The eyes were grouped according to the International Meta-Analysis for Pathologic Myopia (META-PM) classification based on fundus photographs and diffuse atrophy was subdivided into peripapillary diffuse choroidal atrophy (PDCA) or macular diffuse choroidal atrophy (MDCA). Swept-source optical coherence tomography imaging was performed and then the subfoveal choroidal thickness (SFCT) and Bruch's membrane opening diameter (BMOD) were measured. Results: Of the 470 study participants recruited, 373 patients (691 eyes), with a mean age of 42.8 ± 7.2 years, were eligible for the study and included in the analysis. There was no significant difference in SFCT between MDCA and patchy atrophy (M3) groups (P = 1.000), and the BMOD enlarged significantly from no myopic macular lesions to M3 (the P values of multiple comparison tests were all <0.005). Simple linear regression analysis showed that BMOD correlated positively with age (P < 0.001) and axial length (P < 0.001). Multiple linear regression analysis showed that best corrected visual acuity (BCVA) was significantly correlated with age (P = 0.041), axial length (P = 0.001), and BMOD (P = 0.017), but not with SFCT (P = 0.231). Conclusions: The significant variation of BMOD among MMD groups and the correlation between BMOD and BCVA in MMD eyes suggest that BMOD may be an imaging biomarker for monitoring MMD.


Subject(s)
Bruch Membrane , Macular Degeneration , Myopia, Degenerative , Tomography, Optical Coherence , Visual Acuity , Humans , Bruch Membrane/pathology , Bruch Membrane/diagnostic imaging , Male , Tomography, Optical Coherence/methods , Cross-Sectional Studies , Female , Visual Acuity/physiology , Myopia, Degenerative/physiopathology , Myopia, Degenerative/complications , Myopia, Degenerative/diagnosis , Middle Aged , Adult , Macular Degeneration/physiopathology , Macular Degeneration/diagnosis , Choroid/pathology , Choroid/diagnostic imaging , Aged
6.
Invest Ophthalmol Vis Sci ; 65(8): 44, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-39078733

ABSTRACT

Purpose: To understand the microperimetry response characteristics of regions with a truly nonresponding location, which will be useful when considering criteria for end-stage atrophic age-related macular degeneration (AMD). Methods: A simulation model was developed using data from 128 participants with bilateral large drusen at baseline seen over 36 months at 6-month intervals. One hundred thousand pairs of real-world microperimetry testing results were simulated separately with and without one truly nonresponding location, where the sensitivity of one randomly selected location for the former group was derived from the distribution of responses from a truly nonresponding location at the optic nerve head from 60 healthy participants. Results: Only 60% of the simulated test pairs with a truly nonresponding location had ≥1 location that was <0 decibel (dB) on both tests. In contrast, 91% of the simulated test pairs had ≥1 location that was ≤10 dB on both tests, and 87% had ≥1 location that was ≤10 dB on both tests and <0 dB for one of the tests. Of the simulated test pairs without a truly nonresponding location, there were 0.04%, 1.4%, and 0.4% that met these three above criteria, respectively. Conclusions: Regions with a truly nonresponding test location do not almost always show a repeatable absolute scotoma (<0 dB), but instead, much more often a deep visual sensitivity defect (≤10 dB), with or without having an absolute scotoma on one of the tests. These findings are crucial if functional criteria are to be considered as part of a definition of end-stage atrophic AMD.


Subject(s)
Macular Degeneration , Visual Field Tests , Visual Fields , Humans , Visual Field Tests/methods , Visual Fields/physiology , Female , Male , Aged , Macular Degeneration/physiopathology , Macular Degeneration/diagnosis , Geographic Atrophy/physiopathology , Geographic Atrophy/diagnosis , Middle Aged , Visual Acuity/physiology , Aged, 80 and over
7.
Retina ; 44(8): 1351-1359, 2024 Aug 01.
Article in English | MEDLINE | ID: mdl-39047196

ABSTRACT

PURPOSE: In this study, differences in retinal feature visualization of high-resolution optical coherence tomography (OCT) devices were investigated with different axial resolutions in quantifications of retinal pigment epithelium and photoreceptors (PRs) in intermediate age-related macular degeneration. METHODS: Patients were imaged with standard SPECTRALIS HRA + OCT and the investigational High-Res OCT device (both by Heidelberg Engineering, Heidelberg, Germany). Drusen, retinal pigment epithelium, and PR layers were segmented using validated artificial intelligence-based algorithms followed by manual corrections. Thickness and drusen maps were computed for all patients. Loss and thickness measurements were compared between devices, drusen versus nondrusen areas, and early treatment diabetic retinopathy study subfields using mixed-effects models. RESULTS: Thirty-three eyes from 28 patients with intermediate age-related macular degeneration were included. Normalized PR integrity loss was significantly higher with 4.6% for standard OCT compared with 2.5% for High-Res OCT. The central and parafoveal PR integrity loss was larger than the perifoveal loss (P < 0.05). Photoreceptor thickness was increased on High-Res OCT and in nondrusen regions (P < 0.001). Retinal pigment epithelium appeared thicker on standard OCT and above drusen (P < 0.01). CONCLUSION: Our study shows that High-Res OCT is able to identify the condition of investigated layers in intermediate age-related macular degeneration with higher precision. This improved in vivo imaging technology might promote our understanding of the pathophysiology and progression of age-related macular degeneration.


Subject(s)
Retinal Pigment Epithelium , Tomography, Optical Coherence , Humans , Tomography, Optical Coherence/methods , Retinal Pigment Epithelium/pathology , Retinal Pigment Epithelium/diagnostic imaging , Female , Male , Aged , Aged, 80 and over , Photoreceptor Cells, Vertebrate/pathology , Visual Acuity/physiology , Retinal Drusen/diagnosis , Retinal Drusen/diagnostic imaging , Macular Degeneration/diagnosis , Macular Degeneration/physiopathology , Middle Aged
8.
BMJ Open Ophthalmol ; 9(1)2024 Jul 09.
Article in English | MEDLINE | ID: mdl-38981710

ABSTRACT

Lesions of incomplete retinal pigment epithelium and outer retinal atrophy (iRORA) are associated with disease progression in age-related macular degeneration. However, the corresponding functional impact of these precursor lesions is unknown.We present a cross-sectional study of four patients employing clinical-grade MAIA (stimulus size: 0.43°, ~125 µm) and adaptive optics scanning light ophthalmoscope (AOSLO, stimulus size 0.07°, ~20 µm) based microperimetry (MP) to assess the specific impact of iRORA lesions on retinal sensitivity.AOSLO imaging showed overall reduced photoreceptor reflectivity and patches of hyporeflective regions at drusen with interspersed hyper-reflective foci in iRORA regions. MAIA-MP yielded an average retinal sensitivity loss of -7.3±3.1 dB at iRORA lesions compared with the in-eye control. With AOSLO-MP, the corresponding sensitivity loss was 20.1±4.8 dB.We demonstrated that iRORA lesions are associated with a severe impairment in retinal sensitivity. Larger cohort studies will be necessary to validate our findings.


Subject(s)
Macular Degeneration , Retinal Pigment Epithelium , Tomography, Optical Coherence , Visual Field Tests , Humans , Retinal Pigment Epithelium/pathology , Retinal Pigment Epithelium/diagnostic imaging , Cross-Sectional Studies , Macular Degeneration/pathology , Macular Degeneration/diagnosis , Macular Degeneration/physiopathology , Female , Male , Aged , Tomography, Optical Coherence/methods , Visual Field Tests/methods , Visual Acuity/physiology , Aged, 80 and over , Visual Fields/physiology , Ophthalmoscopy/methods , Atrophy/pathology
9.
Sci Rep ; 14(1): 16352, 2024 07 16.
Article in English | MEDLINE | ID: mdl-39013988

ABSTRACT

This study aimed to develop a quantitative analysis program of blood flow velocity by vessel diameter in neovascular age-related macular degeneration (nAMD) subjects using high-speed swept-source optical coherence tomography angiography. This retrospective, observational, cross-sectional study included 10 eyes of healthy volunteers and 4 eyes of patients with representative nAMD. Novel scan patterns and variable interscan time analysis were utilized to measure the flow parameter, a surrogate marker of blood flow velocity, by vessel diameter within different depths. Detected vessels at superficial and deep as well as outer retinal regions were categorized into three vessel diameters (major vessels (> 40 µm), medium vessels (20-40 µm), and capillaries (< 20 µm)). The flow parameter increased with enlarged vessel diameter in all participants at superficial and deep layer. All nAMD subjects, except for type 3 macular neovascularization (MNV), contained a structure dominated by medium vessels at outer retinal region. The mean flow parameter at outer retinal region was type 1 MNV (1.46 ms-1), type 1 + 2 MNV (0.98 ms-1), and polypoidal choroidal vasculopathy, including branching vascular networks (1.46 ms-1). This program provides the possibility to extract the blood flow information at different depths by vessel diameter types, which is considered to be useful tool for evaluating nAMD pathology and activity.


Subject(s)
Macular Degeneration , Retinal Vessels , Tomography, Optical Coherence , Humans , Tomography, Optical Coherence/methods , Male , Female , Aged , Blood Flow Velocity , Cross-Sectional Studies , Retrospective Studies , Macular Degeneration/physiopathology , Macular Degeneration/diagnostic imaging , Macular Degeneration/pathology , Retinal Vessels/diagnostic imaging , Retinal Vessels/physiopathology , Retinal Vessels/pathology , Middle Aged , Aged, 80 and over , Choroidal Neovascularization/diagnostic imaging , Choroidal Neovascularization/physiopathology , Choroidal Neovascularization/pathology , Fluorescein Angiography/methods
10.
Ageing Res Rev ; 99: 102407, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38977082

ABSTRACT

Aging is the greatest risk factor for chronic human diseases, including many eye diseases. Geroscience aims to understand the effects of the aging process on these diseases, including the genetic, molecular, and cellular mechanisms that underlie the increased risk of disease over the lifetime. Understanding of the aging eye increases general knowledge of the cellular physiology impacted by aging processes at various biological extremes. Two major diseases, age-related cataract and age-related macular degeneration (AMD) are caused by dysfunction of the lens and retina, respectively. Lens transparency and light refraction are mediated by lens fiber cells lacking nuclei and other organelles, which provides a unique opportunity to study a single aging hallmark, i.e., loss of proteostasis, within an environment of limited metabolism. In AMD, local dysfunction of the photoreceptors/retinal pigmented epithelium/Bruch's membrane/choriocapillaris complex in the macula leads to the loss of photoreceptors and eventually loss of central vision, and is driven by nearly all the hallmarks of aging and shares features with Alzheimer's disease, Parkinson's disease, cardiovascular disease, and diabetes. The aging eye can function as a model for studying basic mechanisms of aging and, vice versa, well-defined hallmarks of aging can be used as tools to understand age-related eye disease.


Subject(s)
Aging , Cataract , Macular Degeneration , Humans , Macular Degeneration/pathology , Macular Degeneration/physiopathology , Aging/physiology , Aging/pathology , Cataract/physiopathology , Cataract/pathology , Animals , Eye
11.
Invest Ophthalmol Vis Sci ; 65(8): 40, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-39042400

ABSTRACT

Purpose: In aging and early-intermediate age-related macular degeneration (AMD), rod-mediated dark adaptation (RMDA) slows more at 5° superior than at 12°. Using optical coherence tomography angiography (OCTA), we asked whether choriocapillaris flow deficits are related to distance from the fovea. Methods: Persons ≥60 years stratified for AMD via the Age-Related Eye Disease Study's nine-step system underwent RMDA testing. Two adjacent 4.4° × 4.4° choriocapillaris OCTA slabs were centered on the fovea and 12° superior. Flow signal deficits (FD%) in concentric arcs (outer radii in mm, 0.5, 1.5, 2.2, 4.0, and 5.0 superior) were correlated with rod intercept time (RIT) and best-corrected visual acuity (BCVA). Results: In 366 eyes (170 normal, 111 early AMD, 85 intermediate AMD), FD% was significantly worse with greater AMD severity in all regions (overall P < 0.05) and poorest under the fovea (P < 0.0001). In pairwise comparisons, FD% worsened with greater AMD severity (P < 0.05) at distances <2.2 mm. At greater distances, eyes with intermediate, but not early AMD differed from normal eyes. Foveal FD% was more strongly associated with longer RIT at 5° (r = 0.52) than RIT at 12° (r = 0.39) and BCVA (r = 0.21; all P < 0.0001). Choroidal thickness was weakly associated with longer RIT at 5° and 12° (r = 0.10-0.20, P < 0.05) and not associated with AMD severity. Conclusions: Reduced transport across the choriocapillaris-Bruch's membrane-retinal pigment epithelium complex, which contributes to drusen formation under the macula lutea (and fovea), may also reduce retinoid resupply to rods encircling the high-risk area. FD% has potential as a functionally validated imaging biomarker for AMD emergence.


Subject(s)
Aging , Choroid , Dark Adaptation , Fluorescein Angiography , Fovea Centralis , Macular Degeneration , Tomography, Optical Coherence , Visual Acuity , Humans , Choroid/blood supply , Choroid/diagnostic imaging , Tomography, Optical Coherence/methods , Male , Aged , Female , Visual Acuity/physiology , Fovea Centralis/diagnostic imaging , Fovea Centralis/pathology , Fovea Centralis/blood supply , Fovea Centralis/physiopathology , Aging/physiology , Middle Aged , Macular Degeneration/physiopathology , Fluorescein Angiography/methods , Aged, 80 and over , Dark Adaptation/physiology
12.
Invest Ophthalmol Vis Sci ; 65(8): 42, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-39046755

ABSTRACT

Purpose: AI algorithms have shown impressive performance in segmenting geographic atrophy (GA) from fundus autofluorescence (FAF) images. However, selection of artificial intelligence (AI) architecture is an important variable in model development. Here, we explore 12 distinct AI architecture combinations to determine the most effective approach for GA segmentation. Methods: We investigated various AI architectures, each with distinct combinations of encoders and decoders. The architectures included three decoders-FPN (Feature Pyramid Network), UNet, and PSPNet (Pyramid Scene Parsing Network)-and serve as the foundation framework for segmentation task. Encoders including EfficientNet, ResNet (Residual Networks), VGG (Visual Geometry Group) and Mix Vision Transformer (mViT) have a role in extracting optimum latent features for accurate GA segmentation. Performance was measured through comparison of GA areas between human and AI predictions and Dice Coefficient (DC). Results: The training dataset included 601 FAF images from AREDS2 study and validation included 156 FAF images from the GlaxoSmithKline study. The mean absolute difference between grader measured and AI predicted areas ranged from -0.08 (95% CI = -1.35, 1.19) to 0.73 mm2 (95% CI = -5.75,4.29) and DC between 0.884-0.993. The best-performing models were UNet and FPN frameworks with mViT, and the least-performing models were PSPNet framework. Conclusions: The choice of AI architecture impacts GA segmentation performance. Vision transformers with FPN and UNet architectures demonstrate stronger suitability for this task compared to Convolutional Neural Network- and PSPNet-based models. Selecting an AI architecture must be tailored to the specific goals of the project, and developers should consider which architecture is ideal for their project.


Subject(s)
Deep Learning , Geographic Atrophy , Macular Degeneration , Humans , Geographic Atrophy/diagnosis , Macular Degeneration/diagnosis , Macular Degeneration/physiopathology , Algorithms , Fluorescein Angiography/methods , Neural Networks, Computer , Aged , Female , Male
13.
Invest Ophthalmol Vis Sci ; 65(6): 24, 2024 Jun 03.
Article in English | MEDLINE | ID: mdl-38874963

ABSTRACT

Purpose: To examine if changes in hemodynamic measures during an orthostatic challenge were associated with progression of age-related macular degeneration (AMD) over a 4-year period in The Irish Longitudinal Study on Ageing. Methods: Participants with AMD who underwent an active stand (AS) test at wave 1 (2009/2010) and retinal photographs at both wave 1 and wave 3 (2014/2015) were included (N = 159: 121 with no AMD progression and 38 with progression). Beat-to-beat hemodynamic data were non-invasively collected using a Finometer MIDI device during the AS at wave 1, recording systolic blood pressure (sBP), diastolic blood pressure (dBP), mean arterial pressure (MAP), and heart rate. Cardiac output, stroke volume, and total peripheral resistance (TPR) were derived from these measures. Baseline characteristics were compared between groups with and without AMD progression. Mixed-effects linear regression models were used to assess the association between changes in hemodynamic parameters during the AS and AMD progression, controlling for known AMD-associated risk factors. Results: At baseline, increasing age and lower dBP were significantly associated with AMD progression. Mixed-effects models for the period between standing and 10 seconds post-stand revealed significant associations with AMD progression with a steeper drop in dBP and a slower drop in TPR. Between 10 and 20 seconds post-stand, AMD progression was significantly associated with less pronounced reduction in heart rate. Conclusions: These observational data suggest that impaired hemodynamic responses within the first 20 seconds of orthostasis may be associated with the progression of AMD.


Subject(s)
Aging , Blood Pressure , Disease Progression , Heart Rate , Macular Degeneration , Humans , Male , Female , Aged , Macular Degeneration/physiopathology , Ireland/epidemiology , Heart Rate/physiology , Aging/physiology , Blood Pressure/physiology , Longitudinal Studies , Autonomic Nervous System/physiopathology , Aged, 80 and over , Hemodynamics/physiology , Middle Aged , Risk Factors
14.
Optom Vis Sci ; 101(6): 435-442, 2024 Jun 01.
Article in English | MEDLINE | ID: mdl-38913934

ABSTRACT

SIGNIFICANCE: Prior studies with large, highly visible targets report low smooth pursuit gains in individuals with macular degeneration (MD). We show that lower gains persist even when observers are pursuing a target that requires discrimination at the acuity limit. This low gain causes retinal slip, potentially leading to motion blur and target disappearance in the scotoma, which further compromise the visibility of moving object. PURPOSE: In this study, we examine whether the characteristics of smooth pursuit (pursuit gain and placement of the fixational locus relative to the target) change when the task requires dynamic visual acuity. METHODS: Using the scanning laser ophthalmoscope, we recorded smooth pursuit eye movements in 10 eyes of 6 MD participants and 7 eyes of 4 age-matched controls in response to leftward- or rightward-moving annular targets (O) that briefly (300 milliseconds) changed to a Landolt C at one of several time points during the pursuit trial. Participants were asked to pursue the target and indicate the direction of the C opening. RESULTS: Individuals with MD had lower pursuit gains and fewer saccades during the C presentation than during the O, compared with their age-matched peers. Further, pursuit gain, but not the distance of the retinal pursuit locus from the target, predicted task performance in the MD group. CONCLUSIONS: Our findings suggest that compromised pursuit gain in MD participants likely further compromises their dynamic visual acuity and thus ability to view moving targets.


Subject(s)
Macular Degeneration , Pursuit, Smooth , Visual Acuity , Humans , Visual Acuity/physiology , Macular Degeneration/physiopathology , Pursuit, Smooth/physiology , Aged , Male , Female , Middle Aged , Aged, 80 and over , Ophthalmoscopy
15.
J Theor Biol ; 592: 111879, 2024 Sep 07.
Article in English | MEDLINE | ID: mdl-38909882

ABSTRACT

BACKGROUND: Iron-induced oxidative stress was thought to be the reason why the a-wave amplitude of the electroretinogram (ERG) dropped when iron ions were present. It is assumed that reactive oxygen species (ROS) are generated in the presence of iron ions, and this leads to a decrease in hyperpolarization of the photoreceptor. It is known that in age-related macular degeneration (AMD), sodium iodate can induce oxidative stress, apoptosis, and retinal damage, which mimic the effects of clinical AMD. Here, the reduction of the a-wave amplitude in mice with sodium iodate-induced age-related macular degeneration is explained. METHODS: The leading edge of the a-wave is divided into voltages developed by cones and rods. The same oxidative stress model is applied here since sodium iodate causes the creation of ROS in a manner similar to that caused by iron ions, with the exception that the retina is treated as a circuit of various resistances when computing the photoresponse. Moreover, sodium iodate also leads to apoptosis and, hence, may cause misalignment in cones (not in rods) during the initial stage of apoptosis in AMD. To include the effects of apoptosis and shortening in cones and rods, we have used a factor representing the fraction of total cones and rods that are alive. To include the effect of misalignment of cones on the reduction of the a-wave amplitude, we have used the Stiles-Crawford function to calculate the number of photoisomerizations occurring in a photoreceptor misaligned at an angle θ. The results are compared with experimental data. RESULTS: In sodium iodate-treated eyes, the ROS produced can attract calcium ions in the photoreceptor, which increases the calcium influx. In the case of the cones, the inclusion of the misalignment angle in the phototransduction process helps in determining the voltage and slope of the voltage vs. time graph.The smaller the fraction of active photoreceptors, the smaller the amplitude of the a-wave. The calcium influx, misaligned photoreceptors, and total photoreceptor loss all cause the amplitude of the a-wave to decrease, and at any time from the beginning of phototransduction cascade, the calcium influx causes the slope of the a-wave to increase. CONCLUSION: The reduction in the a-wave amplitude in the eyes of sodium iodate-treated mice is attributed to oxidative stress in both cones and rods and cone misalignment, which ultimately lead to apoptosis and vision loss in AMD.


Subject(s)
Electroretinography , Iodates , Macular Degeneration , Oxidative Stress , Reactive Oxygen Species , Retinal Cone Photoreceptor Cells , Animals , Macular Degeneration/pathology , Macular Degeneration/physiopathology , Macular Degeneration/chemically induced , Mice , Oxidative Stress/drug effects , Reactive Oxygen Species/metabolism , Retinal Cone Photoreceptor Cells/drug effects , Retinal Cone Photoreceptor Cells/pathology , Retinal Cone Photoreceptor Cells/metabolism , Apoptosis/drug effects , Retinal Rod Photoreceptor Cells/drug effects , Retinal Rod Photoreceptor Cells/pathology , Retinal Rod Photoreceptor Cells/metabolism , Disease Models, Animal , Models, Biological
16.
Transl Vis Sci Technol ; 13(6): 9, 2024 Jun 03.
Article in English | MEDLINE | ID: mdl-38884546

ABSTRACT

Purpose: To establish the reliability and validity of five performance-based activities of daily living task tests (ADLTT), to correlate structure to function, to evaluate the impact of visual impairment (VI) on age-related macular degeneration (AMD), and to develop new outcome measures. Methods: A multidisciplinary team developed five ADLTTs: (1) reading test (RT); (2) facial expression (FE) recognition; (3) item search (IS) task; (4) money counting (MC) task; and (5) making a drink (MD), tested with binocular and monocular vision. ADLTTs were tested for known-group (i.e., difference between AMD group and controls) and convergent (i.e., correlation to other measures of visual function), validity metrics, and test-retest reliability in 36 patients with VI (visual acuity (logMAR VA > 0.4) in at least one eye caused by AMD versus 36 healthy controls without VI. Results: Compared to controls, AMD patients had a slower reading speed (-77.41 words/min; P < 0.001); took longer to complete MC using monocular worse eye and binocular vision (15.13 seconds and 4.06 seconds longer compared to controls, respectively; P < 0.001); and MD using monocular worse eye vision (9.37 sec; P = 0.033), demonstrating known-group validity. Only RT and MC demonstrated convergent validity, showing correlations with VA, contrast sensitivity, and microperimetry testing. Moderate to good test-retest reliability was observed for MC and MD (interclass correlation coefficient = 0.55 and 0.77; P < 0.001) using monocular worse eye vision. Conclusions: Real-world ADL functioning associated with VI-related AMD can be assessed with our validated ADLTTs, particularly MC and MD. Translational Relevance: This study validates visual function outcome measures that are developed for use in future clinical practice and clinical trials.


Subject(s)
Activities of Daily Living , Macular Degeneration , Visual Acuity , Humans , Macular Degeneration/physiopathology , Macular Degeneration/diagnosis , Female , Male , Aged , Visual Acuity/physiology , Reproducibility of Results , Aged, 80 and over , Middle Aged , Vision Tests/methods , Vision, Binocular/physiology , Reading
17.
Invest Ophthalmol Vis Sci ; 65(6): 26, 2024 Jun 03.
Article in English | MEDLINE | ID: mdl-38884553

ABSTRACT

Purpose: In age-related macular degeneration (AMD), choriocapillaris flow deficits (CCFDs) under soft drusen can be measured using established compensation strategies. This study investigated whether CCFDs can be quantified under calcified drusen (CaD). Methods: CCFDs were measured in normal eyes (n = 30) and AMD eyes with soft drusen (n = 30) or CaD (n = 30). CCFD density masks were generated to highlight regions with higher CCFDs. Masks were also generated for soft drusen and CaD based on both structural en face OCT images and corresponding B-scans. Dice similarity coefficients were calculated between the CCFD density masks and both the soft drusen and CaD masks. A phantom experiment was conducted to simulate the impact of light scattering that arises from CaD. Results: Area measurements of CCFDs were highly correlated with those of CaD but not soft drusen, suggesting an association between CaD and underlying CCFDs. However, unlike soft drusen, the detected optical coherence tomography (OCT) signals underlying CaD did not arise from the defined CC layer but were artifacts caused by the multiple scattering property of CaD. Phantom experiments showed that the presence of highly scattering material similar to the contents of CaD caused an artifactual scattering tail that falsely generated a signal in the CC structural layer but the underlying flow could not be detected. Similarly, CaD also caused an artifactual scattering tail and prevented the penetration of light into the choroid, resulting in en face hypotransmission defects and an inability to detect blood flow within the choriocapillaris. Upon resolution of the CaD, the CC perfusion became detectable. Conclusions: The high scattering property of CaD leads to a scattering tail under these drusen that gives the illusion of a quantifiable optical coherence tomography angiography signal, but this signal does not contain the angiographic information required to assess CCFDs. For this reason, CCFDs cannot be reliably measured under CaD, and CaD must be identified and excluded from macular CCFD measurements.


Subject(s)
Choroid , Fluorescein Angiography , Retinal Drusen , Tomography, Optical Coherence , Humans , Tomography, Optical Coherence/methods , Choroid/blood supply , Choroid/diagnostic imaging , Retinal Drusen/diagnostic imaging , Retinal Drusen/diagnosis , Female , Aged , Male , Fluorescein Angiography/methods , Regional Blood Flow/physiology , Calcinosis/diagnostic imaging , Calcinosis/diagnosis , Aged, 80 and over , Macular Degeneration/diagnosis , Macular Degeneration/physiopathology , Macular Degeneration/diagnostic imaging , Middle Aged , Phantoms, Imaging , Fundus Oculi
18.
Cesk Slov Oftalmol ; 80(Ahead of print): 1-7, 2024.
Article in English | MEDLINE | ID: mdl-38925899

ABSTRACT

This article presents an overview of treatment regimens of drugs containing antivascular endothelial growth factor for the treatment of neovascular form of age-related macular degeneration. Currently, drugs containing antivascular endothelial growth factor are the only effective treatment for this chronic and progressive disease. The treatment regimens for this disease in the last two decades have seen a shift from a simple endeavor to stabilize the disease to achieving maximum improvement of visual acuity and its maintenance, with improvement of the patient's quality of life and a minimal treatment burden on patients and their families. Other goals of the alternative dosing regimens that have replaced the original fixed regimens were greater individualization of the dosing regimen, better patient cooperation, saving financial costs and reducing the burden on application centers. Age-related macular degeneration, whether dry form or wet form, represents a serious health and socioeconomic problem, as the disease is one of the most common causes of severe and irreversible central visual acuity disorders up to the degree of practical blindness of one or both eyes in people over 50 years of age in developed industrialized countries. The most important issue is to ensure early diagnosis of this disease, followed by prompt and continuous treatment with an individualized proactive treatment regimen, with the aim of stabilizing and improving anatomical and functional results.


Subject(s)
Angiogenesis Inhibitors , Macular Degeneration , Humans , Angiogenesis Inhibitors/administration & dosage , Macular Degeneration/drug therapy , Macular Degeneration/diagnosis , Macular Degeneration/physiopathology , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Bevacizumab/administration & dosage , Bevacizumab/therapeutic use
19.
J Biomed Sci ; 31(1): 48, 2024 May 10.
Article in English | MEDLINE | ID: mdl-38730462

ABSTRACT

Retinal degenerative diseases, including diabetic retinopathy (DR) and age-related macular degeneration (AMD), loom as threats to vision, causing detrimental effects on the structure and function of the retina. Central to understanding these diseases, is the compromised state of the blood-retinal barrier (BRB), an effective barrier that regulates the influx of immune and inflammatory components. Whether BRB breakdown initiates retinal distress, or is a consequence of disease progression, remains enigmatic. Nevertheless, it is an indication of retinal dysfunction and potential vision loss.The intricate intercellular dialogues among retinal cell populations remain unintelligible in the complex retinal milieu, under conditions of inflammation and oxidative stress. The retina, a specialized neural tissue, sustains a ceaseless demand for oxygen and nutrients from two vascular networks. The BRB orchestrates the exchange of molecules and fluids within this specialized region, comprising the inner BRB (iBRB) and the outer BRB (oBRB). Extracellular vesicles (EVs) are small membranous structures, and act as messengers facilitating intercellular communication in this milieu.EVs, both from retinal and peripheral immune cells, increase complexity to BRB dysfunction in DR and AMD. Laden with bioactive cargoes, these EVs can modulate the retinal microenvironment, influencing disease progression. Our review delves into the multifaceted role of EVs in retinal degenerative diseases, elucidating the molecular crosstalk they orchestrate, and their microRNA (miRNA) content. By shedding light on these nanoscale messengers, from their biogenesis, release, to interaction and uptake by target cells, we aim to deepen the comprehension of BRB dysfunction and explore their therapeutic potential, therefore increasing our understanding of DR and AMD pathophysiology.


Subject(s)
Blood-Retinal Barrier , Extracellular Vesicles , Blood-Retinal Barrier/metabolism , Blood-Retinal Barrier/physiopathology , Extracellular Vesicles/metabolism , Humans , Diabetic Retinopathy/physiopathology , Diabetic Retinopathy/metabolism , Retinal Diseases/physiopathology , Retinal Diseases/metabolism , Macular Degeneration/physiopathology , Macular Degeneration/metabolism , Animals
20.
Int Ophthalmol ; 44(1): 228, 2024 May 23.
Article in English | MEDLINE | ID: mdl-38780873

ABSTRACT

AIM: It is known that a healthy and balanced diet plays an important role in the etiopathogenesis of age-related macular degeneration (AMD). The aim of this study is to show the possible relationship between the prognostic nutritional index (PNI) and AMD. METHODS: This observational longitudinal study included 50 patients who were diagnosed with AMD and 100 participants as control group in the Ophthalmology Polyclinic of Kirsehir Ahi Evran Training and Research Hospital between December 2022 and February 2023. The PNI scores of the patients were calculated with the formula (10 × albumin (g/L) + (0.005 × total lymphocyte count), using routine hemogram and biochemical assays. RESULTS: One hundred fifty participants were included in the study (average age: 73.7 ± 8.6 years, male: 53.3%). When adjusted for age, sex, and total comorbidity index score via multivariate logistic regression analysis, the association between AMD and PNI scores (OR = 0.3; CI: 0.2-0.4; p = 0.01) and Charlson Comorbidity Index (CCI) scores (OR = 6.8; CI: 2.8-16.6; p = 0.01) was statistically significant. CONCLUSION: The use of PNI scores may be practical and useful in routine clinical practice for predicting AMD.


Subject(s)
Macular Degeneration , Nutrition Assessment , Nutritional Status , Humans , Male , Macular Degeneration/diagnosis , Macular Degeneration/physiopathology , Female , Aged , Prognosis , Aged, 80 and over , Follow-Up Studies , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL